Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatocellular Carcinoma
100%
Chemotherapy Resistance
100%
Pyruvate Kinase M2 (PKM2)
100%
Transarterial Chemoembolization
100%
Non-responders
35%
Knockdown
28%
Shikonin
28%
Hepatocellular Carcinoma Cells
21%
Pharmacological Inhibitors
14%
Hypoxia
14%
Rate-limiting Enzyme
14%
PDCs
14%
Organoids
14%
Glycolysis Pathway
14%
Quantitative PCR
7%
Tumor
7%
Navigator
7%
Immunoblotting
7%
Possible Mechanisms
7%
Doxorubicin
7%
Chemotherapy
7%
Pharmacologic
7%
Functional Studies
7%
Short Hairpin RNA (shRNA)
7%
Cisplatin
7%
Cell Metabolism
7%
Resistance Mechanisms
7%
Therapeutic Potential
7%
Response to Chemotherapy
7%
Drug Sensitivity
7%
Transcriptomics
7%
Glycolysis
7%
Gene Pathway Analysis
7%
Oxygen Dependence
7%
Putative Drug Targets
7%
Potential Drivers
7%
Interventional Procedures
7%
Aggressive Phenotype
7%
Hepatocellular Carcinoma Patients
7%
Patient-derived Cell Line
7%
Treatment Resistance
7%
Prognostic Signature
7%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Transcatheter Arterial Chemoembolization
100%
In Vitro
28%
Hepatocellular Carcinoma Cell Line
21%
Cell Line
14%
Hypoxia
14%
Organoid
14%
Real-Time Polymerase Chain Reaction
7%
Neoplasm
7%
Doxorubicin
7%
Short Hairpin RNA
7%
Cisplatin
7%
Transcriptomics
7%
Immunoblotting
7%
Cell Metabolism
7%
Drug Sensitivity
7%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Shikonin
57%
Chemotherapy
28%
Hypoxia
28%
Neoplasm
14%
Western Blot
14%
Short Hairpin RNA
14%
Cisplatin
14%
Doxorubicin
14%
Biochemistry, Genetics and Molecular Biology
Enzyme
20%
Real-Time Polymerase Chain Reaction
10%
Transcriptomics
10%
Small Hairpin RNA
10%
Cisplatin
10%
Drug Sensitivity
10%
Cell Metabolism
10%
Gene Signature
10%
Doxorubicin
10%
Immunoblotting
10%